date,title,source
Oct-19-18,"Detailed Research: Economic Perspectives on W.W. Grainger, Jabil, Grand Canyon Education, Sage Therapeutics, H. B. Fuller, and Jazz Pharmaceuticals  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Oct-23-18,"Sage Therapeutics to Report Third Quarter 2018 Financial Results on Tuesday, November 6, 2018",Business Wire
Oct-24-18,Today's Research Reports on Trending Tickers: Sage Therapeutics and Ionis Pharmaceuticals,ACCESSWIRE
Oct-25-18,Cramer's lightning round: 'Take the money and run' with takeover stock Mazor Robotics,CNBC
Oct-26-18,Sage Therapeutics Turned Down - Don't Rush to Be a Buyer,TheStreet.com
Oct-29-18,FDA set to review new drugs aimed at fighting depression,CNBC Videos
Oct-31-18,Today's Research Reports on Trending Tickers: Exelixis and Sage Therapeutics,ACCESSWIRE
Nov-05-18,Todays Research Reports on Stocks to Watch: AcelRx Pharmaceuticals and Sage Therapeutics,ACCESSWIRE
Nov-05-18,Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),Business Wire
Nov-06-18,Edited Transcript of SAGE earnings conference call or presentation 6-Nov-18 1:00pm GMT,Thomson Reuters StreetEvents
Nov-06-18,Sage Therapeutics Announces Third Quarter 2018 Financial Results and Highlights Pipeline and Business Progress,Business Wire
Nov-07-18,Sage Therapeutics to Present at Stifel 2018 Healthcare Conference,Business Wire
Nov-12-18,"Stocks making the biggest moves after hours: PG&E, Eventbrite and more",CNBC
Nov-16-18,Today's Research Reports on Trending Tickers: Sarepta Therapeutics and Sage Therapeutics,ACCESSWIRE
Nov-20-18,Sage Therapeutics Receives Notification of PDUFA Extension for ZULRESSO (brexanolone) Injection,Business Wire
Nov-21-18,Sage Therapeutics to Present at Piper Jaffray 30th Annual Healthcare Conference,Business Wire
Nov-26-18,Today's Research Reports on Trending Tickers: GW Pharmaceuticals and Sage Therapeutics,ACCESSWIRE
Nov-29-18,"New Research: Key Drivers of Growth for Upland Software, VICI Properties, Sage Therapeutics, Jack Henry & Associates, T2 Biosystems, and Tata Motors  Factors of Influence, Major Initiatives and Sustained Production",GlobeNewswire
Nov-30-18,Today's Research Reports on Trending Tickers: Alnylam Pharmaceuticals and Sage Therapeutics,ACCESSWIRE
Dec-10-18,Hedge Funds Are Selling SAGE Therapeutics Inc (SAGE),Insider Monkey
Dec-12-18,Here's Why Marinus Pharmaceuticals Is Sinking Today,Motley Fool
Dec-14-18,Today's Research Reports on Trending Tickers: Sage Therapeutics and Altimmune,ACCESSWIRE
Dec-20-18,"DAFNA Capital Management Return, AUM and Holdings",Insider Monkey
Dec-20-18,"Has Sage Therapeutics, Inc. (NASDAQ:SAGE) Got Enough Cash?",Simply Wall St.
Dec-24-18,Biotech Buying Spree: Why These 3 Stocks Could Get Deals In 2019,Investor's Business Daily
Dec-27-18,"Sage Therapeutics to Present at J.P. Morgan Healthcare Conference on Tuesday, January 8, 2019",Business Wire
Jan-03-19,Implied Volatility Surging for Sage Therapeutics (SAGE) Stock Options,Zacks
Jan-04-19,Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),Business Wire
Jan-07-19,Biotech Stocks Post Double-Digit Gains in Monday Surge,TheStreet.com
Jan-07-19,What Happened in the Stock Market Today,Motley Fool
Jan-07-19,Sage Therapeutics's stock shoots higher after postpartum depression treatment's positive trial results,MarketWatch
Jan-07-19,Why Sage Therapeutics Is Skyrocketing Today,Motley Fool
Jan-07-19,SAGE Therapeutics Soars on Promising Postpartum Drug-Trial Results,TheStreet.com
Jan-07-19,"Report: Developing Opportunities within General Mills, Philip Morris International, Sage Therapeutics, CNA Financial, Hess, and AutoNation  Future Expectations, Projections Moving into 2019",GlobeNewswire
Jan-07-19,Sage Therapeutics to Provide Update on Key 2019 Initiatives at J.P. Morgan Healthcare Conference,Business Wire
Jan-07-19,Today's Research Reports on Trending Tickers: Amarin Corporation and Sage Therapeutics,ACCESSWIRE
Jan-07-19,Pill for postpartum depression by Cambridge's Sage succeeds in late-stage trial,American City Business Journals
Jan-07-19,Sage's oral postpartum depression treatment succeeds in late-stage study,Reuters
Jan-07-19,Sage Therapeutics Announces SAGE-217 Meets Primary and Secondary Endpoints in Phase 3 Clinical Trial in Postpartum Depression,Business Wire
Jan-08-19,Here's Why Axsome Therapeutics Has Been a Rocket Ship This Week,Motley Fool
Jan-09-19,"Eyeing FDA approval, Sage lays out strategy for dual postpartum depression drugs",American City Business Journals
Jan-09-19,"Biotech Stock Roundup: LOXO, CELG Gain, J.P. Morgan Healthcare Conference in Focus",Zacks
Jan-10-19,3 Biggest Stories at the J.P. Morgan Healthcare Conference This Year,Motley Fool
Jan-11-19,The 3 Best-Performing Biotech Stocks at the J.P. Morgan Healthcare Conference,Motley Fool
Jan-15-19,3 Small-Cap Stocks With Big-Cap Potential,Motley Fool
Jan-15-19,Here's How The Government Shutdown Will Affect These Medical Stocks,Investor's Business Daily
Jan-16-19,Ligand Crashes To Nearly 2-Year Low After Short-Seller Bashes It,Investor's Business Daily
Jan-16-19,Today's Research Reports on Trending Tickers: Amicus Therapeutics and Sage Therapeutics,ACCESSWIRE
Jan-17-19,Ligand (LGND) Takes a Hit on Citron's Negative Research Report,Zacks
Jan-17-19,Citron Says Ligand Has 80% Downside in Explosive Note,Investopedia
Jan-23-19,Sage Therapeutics Appoints Elizabeth Barrett and George Golumbeski to Board of Directors,Business Wire
Jan-24-19,Three Companies Using AI and Innovation to Lead Healthcare Sector,ACCESSWIRE
Jan-31-19,Here are Boston-area biotechs pursuing Parkinson's treatments,American City Business Journals
Feb-05-19,"Sage Therapeutics to Report Fourth Quarter and Full Year 2018 Financial Results on Tuesday, February 19, 2019",Business Wire
Feb-07-19,Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),Business Wire
Feb-08-19,"Factors of Influence in 2019, Key Indicators and Opportunity within New Relic, Clean Harbors, Sage Therapeutics, Accelerate Diagnostics, Fortinet, and Colfax  New Research Emphasizes Economic Growth",GlobeNewswire
Feb-14-19,Here Are 5 Biotech Stocks To Love This Valentine's Day: Analyst,Investor's Business Daily
Feb-19-19,Edited Transcript of SAGE earnings conference call or presentation 19-Feb-19 1:00pm GMT,Thomson Reuters StreetEvents
Feb-19-19,Sage Therapeutics Inc (SAGE) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-19-19,Sage Therapeutics Announces Fourth Quarter and Full Year 2018 Financial Results and Highlights Pipeline and Business Progress,Business Wire
Feb-19-19,"SAGE Therapeutics, Inc. to Host Earnings Call",ACCESSWIRE
Feb-20-19,Edited Transcript of SAGE earnings conference call or presentation 19-Feb-19 1:00pm GMT,Thomson Reuters StreetEvents
Feb-25-19,Sage Therapeutics Prices Public Offering of Common Stock,Business Wire
Feb-25-19,"Stocks making the biggest moves after hours: Etsy, Hertz, Shake Shack and more",CNBC
Feb-25-19,Sage Therapeutics Announces Proposed Public Offering of Common Stock,Business Wire
Feb-27-19,"Sage Therapeutics Announces Closing of $575 Million Public Offering of Common Stock, Including Full Exercise of Option to Purchase Additional Shares",Business Wire
Mar-05-19,"Market Trends Toward New Normal in Macy's, Comerica, JetBlue Airways, Intersect ENT, Stanley Black & Decker, and Sage Therapeutics  Emerging Consolidated Expectations, Analyst Ratings",GlobeNewswire
Mar-05-19,Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),Business Wire
Mar-06-19,"More biotech takeover targets coming, says Jefferies top analyst",CNBC Videos
Mar-07-19,"Why News From J&J, Allergan Could Be A Boon For This Biotech Stock",Investor's Business Daily
Mar-18-19,"Market Morning: Black Box Details, Brexit Referendum 2, Postpartum Drug, Oil Short Squeeze?",Market Exclusive
Mar-19-19,[$$] Postpartum Depression Drug Gets FDA Approval,The Wall Street Journal
Mar-19-19,FDA approves drug for treating postpartum depression,Associated Press
Mar-19-19,Sage gets U.S. approval for first postpartum depression therapy,Reuters
Mar-19-19,"Sage Therapeutics Announces FDA Approval of ZULRESSO (brexanolone) Injection, the First and Only Treatment Specifically Indicated for Postpartum Depression",Business Wire
Mar-19-19,FDA approves first drug specifically to treat postpartum depression,MarketWatch
Mar-19-19,Sage Therapeutics Surges on FDA Approval of Postpartum Depression Drug,TheStreet.com
Mar-19-19,Sage Therapeutics stock rises after FDA approves first postpartum depression drug Zulresso,CNBC
Mar-19-19,FDA approves Sage's first-ever treatment for postpartum depression,American City Business Journals
Mar-19-19,Sage gets U.S. approval for first postpartum depression therapy,Reuters
Mar-19-19,"FedEx Sinks After Hours; Smartsheet Dives, Sage Rises",Investing.com
Mar-20-19,Is Sage Therapeutics a Good Stock to Buy Now?,Motley Fool
Mar-20-19,Fed Stops the Rate Madness: Cramer's 'Mad Money' Recap (Wednesday 3/20/19),TheStreet.com
Mar-20-19,Sage Therapeutics CEO: Getting the first postpartum depre...,CNBC Videos
Mar-20-19,This Biotech Stock Grabbed A First In Depression  So What's Next?,Investor's Business Daily
Mar-20-19,"The Late Morning Rundown: March 20, 2019",CNBC Videos
Mar-20-19,Sage's First-Of-Its-Kind Postpartum Depression Drug Clears FDA Hurdle: What You Need to Know,Benzinga
Mar-20-19,"Shares of Sage Therapeutics up on Zulresso approval, but analysts expect a slow rollout",MarketWatch
Mar-20-19,Sage Stock Pops on FDA Approval for Postpartum Depression Drug,InvestorPlace
Mar-20-19,"Stocks Lose Ground Ahead Of Federal Reserve; FedEx, Monster Tumble",Investor's Business Daily
Mar-20-19,This Postpartum-Depression Drug Has Unusual Potential,Bloomberg
Mar-20-19,"FedEx, Federal Reserve, Google, AMD, Sage Therapeutics - 5 Things You Must Know",TheStreet.com
Mar-21-19,A Big Outside Day and Lower Close on Sage Therapeutics Looks Bearish to Me,TheStreet.com
Mar-21-19,"Shares of Sage Therapeutics up on Zulresso approval, but analysts expect a slow rollout",MarketWatch
Mar-25-19,5 biotech stocks that could be the next big winners,MarketWatch
Apr-01-19,"The Zacks Analyst Blog Highlights: Celgene, Puma, Exelixis, Enanta and Sage",Zacks
Apr-03-19,Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),Business Wire
Apr-18-19,"Sage Therapeutics to Report First Quarter 2019 Financial Results on Thursday, May 2, 2019",Business Wire
Apr-24-19,Did Hedge Funds Drop The Ball On SAGE Therapeutics Inc (SAGE) ?,Insider Monkey
Apr-26-19,Analysts point to potential Biogen M&A options after Alzheimer's failure,American City Business Journals
Apr-29-19,"SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Concerning Possible Breaches of Fiduciary Duty by the Board of Directors of Sage Therapeutics, Inc.",GlobeNewswire
May-02-19,Sage Therapeutics Announces First Quarter 2019 Financial Results and Highlights Pipeline and Business Progress,Business Wire
May-02-19,"SAGE Therapeutics, Inc. to Host Earnings Call",ACCESSWIRE
May-02-19,These 6 biotech stocks are promising takeover targets,MarketWatch
May-06-19,Sage Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4),Business Wire
May-07-19,Sage Therapeutics to Present at Bank of America Merrill Lynch 2019 Health Care Conference,Business Wire
May-08-19,Small-Cap Stocks to Watch in May,Motley Fool
May-09-19,New England Venture Capital Association names 2019 NEVY Awards winners,American City Business Journals
May-13-19,Edited Transcript of SAGE earnings conference call or presentation 2-May-19 12:00pm GMT,Thomson Reuters StreetEvents
May-14-19,Sage Therapeutics to Present at 2019 RBC Capital Markets Global Healthcare Conference,Business Wire
May-20-19,Ligand Grants Preclinical Candidate Rights to UK-based Firm,Zacks
May-22-19,"Are Investors Undervaluing Sage Therapeutics, Inc. (NASDAQ:SAGE) By 29%?",Simply Wall St.
May-23-19,"Wedbush Securities Senior Vice President of Equity Research Laura Chico, Ph.D. Initiates Coverage on Six Stocks in the Healthcare and BioTech Space - ACER, ACOR, ALNX, BIIB, DOVA and SAGE",PR Newswire
May-24-19,Sage Therapeutics Inc (SAGE) President & CEO Jeffrey M Jonas Sold $16.5 million of Shares,GuruFocus.com
May-29-19,Sage Therapeutics Inc (SAGE) President & CEO Jeffrey M Jonas Sold $15 million of Shares,GuruFocus.com
